Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan T Luskin

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of Allergy and Clinical Immunology|April 5, 2005
What the asthma end points we know and love do and do not tell usAllan T Luskin
Immunology and Allergy Clinics of North America|April 4, 2017
Pharmacoeconomics of Biologic TherapyDon A Bukstein, Allan T Luskin
American Journal of Therapeutics|July 1, 1996
Anaphylaxis and Anaphylactoid Reactions: Diagnosis and ManagementAllan T. Luskin, Susan S. Luskin
Allergy and Asthma Proceedings|April 12, 2011
Exhaled nitric oxide as a tool in managing and monitoring difficult-to-treat asthmaDon Bukstein, Allan T Luskin, Elizabeth A Brooks
Allergy and Asthma Proceedings|July 26, 2011
The reality of adherence to rhinitis treatment: identifying and overcoming the barriersDon Bukstein, Allan T Luskin, Judith Rosen Farrar
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 31, 2003
"Real-world" effectiveness of daily controller medicine in children with mild persistent asthmaDon A Bukstein, Allan T Luskin, Avi Bernstein
Managed Care Interface|March 24, 2004
Clinical and economic effects of suboptimally controlled asthmaJ Lyle Bootman, William H Crown, Allan T Luskin
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 6, 2006
Symptom control and improved functioning: the effect of omalizumab on asthma-related quality of life (ARQL)Allan T Luskin, Mark Kosinski, Brian W Bresnahan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 14, 2004
Changing physician prescribing patterns through problem-based learning: an interactive, teleconference case-based education program and review of problem-based learningRay S Davis, Don A Bukstein, Allan T Luskin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2014
Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthmaAllan T Luskin, Bradley E Chipps, Lawrence Rasouliyan, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of Allergy and Clinical Immunology|April 5, 2005
What the asthma end points we know and love do and do not tell usAllan T Luskin
Immunology and Allergy Clinics of North America|April 4, 2017
Pharmacoeconomics of Biologic TherapyDon A Bukstein, Allan T Luskin
American Journal of Therapeutics|July 1, 1996
Anaphylaxis and Anaphylactoid Reactions: Diagnosis and ManagementAllan T. Luskin, Susan S. Luskin
Allergy and Asthma Proceedings|April 12, 2011
Exhaled nitric oxide as a tool in managing and monitoring difficult-to-treat asthmaDon Bukstein, Allan T Luskin, Elizabeth A Brooks
Allergy and Asthma Proceedings|July 26, 2011
The reality of adherence to rhinitis treatment: identifying and overcoming the barriersDon Bukstein, Allan T Luskin, Judith Rosen Farrar
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 31, 2003
"Real-world" effectiveness of daily controller medicine in children with mild persistent asthmaDon A Bukstein, Allan T Luskin, Avi Bernstein
Managed Care Interface|March 24, 2004
Clinical and economic effects of suboptimally controlled asthmaJ Lyle Bootman, William H Crown, Allan T Luskin
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 6, 2006
Symptom control and improved functioning: the effect of omalizumab on asthma-related quality of life (ARQL)Allan T Luskin, Mark Kosinski, Brian W Bresnahan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 14, 2004
Changing physician prescribing patterns through problem-based learning: an interactive, teleconference case-based education program and review of problem-based learningRay S Davis, Don A Bukstein, Allan T Luskin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2014
Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthmaAllan T Luskin, Bradley E Chipps, Lawrence Rasouliyan, et al.
Pageof 2